Perosphere
Pharmaceuticals, 20 Kenosia Avenue, Danbury, , 6810, Connecticut, United States, 11-50 Employees
Phone Number: +14*********
Who is PEROSPHERE
Perosphere is a private specialty pharmaceutical company focused on developing rescue medications. Perosphere employs rational drug design to invent proprietary new small molecules for ta...
Read More
-
Headquarters: 20 Kenosia Avenue, Danbury, Connecticut, 6810, United States
-
Date Founded: 2011
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from PEROSPHERE
Perosphere Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Perosphere
Answer: Perosphere's headquarters are located at 20 Kenosia Avenue, Danbury, , 6810, Connecticut, United States
Answer: Perosphere's phone number is +14*********
Answer: Perosphere's official website is https://perosphere.com
Answer: Perosphere's revenue is $5 Million to $10 Million
Answer: Perosphere's SIC: 2834
Answer: Perosphere's NAICS: 325412
Answer: Perosphere has 11-50 employees
Answer: Perosphere is in Pharmaceuticals
Answer: Perosphere contact info: Phone number: +14********* Website: https://perosphere.com
Answer: Perosphere is a private specialty pharmaceutical company focused on developing rescue medications. Perosphere employs rational drug design to invent proprietary new small molecules for targeted therapeutic indications. Perosphere selectively identifies and develops new chemical entities and other therapeutics that can be used as rescue drugs. Perosphere also identifies market opportunities where application of drug delivery technology to an already marketed drug can create a new patent-protected medical use or enhance safety, efficacy or ease of use. Perosphere recognizes the scientific and marketing opportunities afforded by its drug candidates and pursues clinical development using the U.S. FDA's 505(b)(2) regulatory pathway whenever possible. The 505(b)(2) pathway enables the expedited development of drug candidates that are based on drugs already demonstrated to be safe and effective. Perosphere's proprietary drug delivery technology is protected by over 30 issued and 10 pending patents.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month